Sequential Intravenous-Oral Administration of Ciprofloxacin vs Ceftazidime in Serious Bacterial Respiratory Tract Infections
- 1 September 1989
- Vol. 96 (3) , 528-537
- https://doi.org/10.1378/chest.96.3.528
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The QuinolonesMayo Clinic Proceedings, 1987
- Treatment of respiratory tract infections with ciprofloxacinJournal of Antimicrobial Chemotherapy, 1986
- Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillinJournal of Antimicrobial Chemotherapy, 1986
- Ciprofloxacin in the treatment of pneumoniaAntimicrobial Agents and Chemotherapy, 1986
- Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Penetration of ciprofloxacin into bronchial secretionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulareAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivativesAntimicrobial Agents and Chemotherapy, 1984
- In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatisAntimicrobial Agents and Chemotherapy, 1984
- Antibiotic Susceptibility Testing by a Standardized Single Disk MethodAmerican Journal of Clinical Pathology, 1966